Herbalife Acquires Pro2col Health, Pruvit Ventures Assets and 51% of Link BioSciences

Cristiano Ronaldo Takes 10% Stake in Herbalife's Pro2col Platform

February 21, 2026

Healthcare Services

Cristiano Ronaldo invested $7.5 million to acquire a 10% equity stake in HBL Pro2col Software, LLC, an indirect, wholly owned Herbalife subsidiary that holds the company's Pro2col digital health and wellness platform. The investment includes Ronaldo providing services and sponsorship rights and supports Herbalife's strategy to expand its data-driven, AI-enabled personalized wellness capabilities ahead of broader commercial launches.

Kadenwood Acquires Probulin Probiotic Brand from HempFusion Wellness

January 18, 2023

Food & Beverage

Kadenwood, a Newport Beach-based plant‑based wellness company, has acquired Probulin, a probiotic and microbiome health brand previously owned by HempFusion Wellness, Inc. The deal expands Kadenwood’s portfolio into the probiotics category and adds retail and e‑commerce distribution channels to accelerate growth across natural, drug and mass retail outlets.

Sanofi to Acquire Provention Bio for $2.9 Billion

March 13, 2023

Pharmaceuticals

Sanofi has entered into an agreement to acquire Provention Bio for $25.00 per share in cash, valuing the deal at approximately $2.9 billion. The transaction will be implemented via a cash tender offer followed by a merger, with completion expected in the second quarter of 2023 subject to customary closing conditions.

Nestlé Health Science Acquires Majority Stake in Vital Proteins

June 10, 2020

Food & Beverage

Nestlé Health Science (NHSc), a subsidiary of Nestlé, agreed to acquire a majority stake in Vital Proteins, the US market leader in collagen-based supplements, beverages and food products. Vital Proteins will continue to operate as a standalone business under CEO Kurt Seidensticker, with the deal intended to accelerate global expansion and product innovation.

Johnson & Johnson to Acquire Proteologix, Inc.

May 16, 2024

Biotechnology

Johnson & Johnson entered into a definitive agreement to acquire privately held biotechnology company Proteologix for $850 million in cash, with potential additional milestone payments. The deal is expected to close mid-year 2024 subject to antitrust clearance and customary closing conditions, expanding J&J’s bispecific antibody pipeline for immune-mediated diseases including atopic dermatitis and asthma.

PSB Holdings Formed in $1.3B Merger of Sunbasket and Prüvit Ventures

January 31, 2022

Food & Beverage

Sunbasket and Prüvit Ventures completed an all-stock $1.3 billion merger to form PSB Holdings, with Prüvit shareholders owning 60% and Sunbasket shareholders owning 40% of the new holding company. The combined business will operate Sunbasket and Prüvit as wholly owned subsidiaries to build a personalized wellness platform that combines ketogenic supplements, community and at-home meal kits.